Office of Cancer Survivorship

The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.

Stay up-to-date on everything from OCS @NCICancerSurv

OCS in the Media

Spotlight

Upcoming Presentation

January 2022 — OCS Director’s Series, in Partnership with the NCI Center for Global Health

Register now for Dr. Stephen Kimani’s presentation “Missed Opportunities for Supportive Care across the Cancer Care Continuum in Malawi: Perspectives from Survivors of Lymphoma and Breast Cancer" on January 25, 2022, 2-3 p.m. ET.

Cancer Currents Blog

October 2021 — From Scan to Scan: The Challenges of Living with Metastatic Cancer

A growing population of people living with advanced or metastatic cancer has raised questions about the unique needs of these individuals and how to improve their care.

Video

October 2021 — Office of Cancer Survivorship Vision, Mission, and Future

Watch this new video from OCS Director Dr. Emily Tonorezos as she discusses the vision, mission, and future of OCS.

View More News and Highlights

Funding Opportunities

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity

EXPIRATION DATE: January 08, 2022

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment

EXPIRATION DATE: June 09, 2022

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization

EXPIRATION DATE: September 08, 2022

About The Office of Cancer Survivorship

An individual is considered a cancer survivor from the time of diagnosis, through the balance of life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.

OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.